Addressing the advancement of neuro-vascular health through study of cilia functions in brain blood vessel development, Cian personnel are focused on creating diagnostic tools that utilize cilia as biomarkers to assess vascular health and identify diseases. Additionally, the firm develops prognostication tools to predict disease progression by analyzing ciliary protein biomarkers. Also being explored are therapeutic strategies aimed at enhancing vascular stability, with a particular emphasis on improving outcomes related to brain injuries.
